 Ondansetron
"Ondansetron" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Descriptor ID |
D017294
|
| MeSH Number(s) |
D03.383.129.308.690 D03.633.100.473.144.500 D03.633.300.148.500
|
| Concept/Terms |
Ondansetron Hydrochloride- Ondansetron Hydrochloride
- Hydrochloride, Ondansetron
- Ondansetron Monohydrochloride
- Monohydrochloride, Ondansetron
- Ondansetron Monohydrochloride Dihydrate
- Dihydrate, Ondansetron Monohydrochloride
- Monohydrochloride Dihydrate, Ondansetron
|
Below are MeSH descriptors whose meaning is more general than "Ondansetron".
Below are MeSH descriptors whose meaning is more specific than "Ondansetron".
This graph shows the total number of publications written about "Ondansetron" by people in this website by year, and whether "Ondansetron" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2005 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2009 | 0 | 1 | 1 | | 2014 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ondansetron" by people in Profiles.
-
April MD, Oliver JJ, Davis WT, Ong D, Simon EM, Ng PC, Hunter CJ. In reply. Ann Emerg Med. 2019 02; 73(2):209-210.
-
April MD, Oliver JJ, Davis WT, Ong D, Simon EM, Ng PC, Hunter CJ. Aromatherapy Versus Oral Ondansetron for?Antiemetic Therapy Among Adult Emergency?Department Patients: A Randomized Controlled Trial. Ann Emerg Med. 2018 08; 72(2):184-193.
-
Prin M, Guglielminotti J, Moitra V, Li G. Prophylactic Ondansetron for the Prevention of Intrathecal Fentanyl- or Sufentanil-Mediated Pruritus: A Meta-Analysis of Randomized Trials. Anesth Analg. 2016 Feb; 122(2):402-9.
-
Elkomy MH, Sultan P, Carvalho B, Peltz G, Wu M, Clavijo C, Galinkin JL, Drover DR. Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome. Clin Pharmacol Ther. 2015 Feb; 97(2):167-76.
-
Monte AA, Heard KJ, Campbell J, Hamamura D, Weinshilboum RM, Vasiliou V. The effect of CYP2D6 drug-drug interactions on hydrocodone effectiveness. Acad Emerg Med. 2014 Aug; 21(8):879-85.
-
Freedman SB, Hall M, Shah SS, Kharbanda AB, Aronson PL, Florin TA, Mistry RD, Macias CG, Neuman MI. Impact of increasing ondansetron use on clinical outcomes in children with gastroenteritis. JAMA Pediatr. 2014 Apr; 168(4):321-9.
-
Ortiz NC, O'Neill HC, Marks MJ, Grady SR. Varenicline blocks ?2*-nAChR-mediated response and activates ?4*-nAChR-mediated responses in mice in vivo. Nicotine Tob Res. 2012 Jun; 14(6):711-9.
-
Wildeboer KM, Zheng L, Choo KS, Stevens KE. Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism. Brain Res. 2009 Dec 01; 1300:41-50.
-
Gore L, Chawla S, Petrilli A, Hemenway M, Schissel D, Chua V, Carides AD, Taylor A, Devandry S, Valentine J, Evans JK, Oxenius B. Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability. Pediatr Blood Cancer. 2009 Feb; 52(2):242-7.
-
Langston WT, Wathen JE, Roback MG, Bajaj L. Effect of ondansetron on the incidence of vomiting associated with ketamine sedation in children: a double-blind, randomized, placebo-controlled trial. Ann Emerg Med. 2008 Jul; 52(1):30-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|